Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction

Kiyokazu Hiwatashi, Taiga Tamiya, Eiichi Hasegawa, Tomohiro Fukaya, Masayuki Hashimoto, Kyosuke Kakoi, Ikko Kashiwagi, Akihiro Kimura, Naoko Inoue, Rimpei Morita, Hideo Yasukawa, Akihiko Yoshimura

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Inflammation has been demonstrated to play important roles in tumorigenesis, tumor progression, and metastasis. STAT3 has been shown to be frequently activated in a variety of human cancer cells and STAT3 signaling promotes the growth and survival of tumor cells. However, the role of STAT3 of myeloid cells associated with tumors is currently unknown. Suppressor of cytokine signaling-3 (SOCS3) has been shown to be a negative regulator of STAT3. In this study, we used macrophage specific SOCS3 conditional knockout (cKO) mice to investigate the effect of the hyperactivation of STAT3 in macrophages on tumor development and metastasis. In a subcutaneous transplantation model of B16F10 melanoma cells, although tumor sizes were not significantly different, SOCS3-cKO mice survived longer than wild-type (WT) mice did. SOCS3-cKO mice exhibited fewer lung and liver metastatic tumor nodules than WT mice when B16F10 was challenged intravenously. SOCS3-/- macrophages stimulated with tumor lysates in vitro exhibited prolonged STAT3 phosphorylation and produced less amount of TNFα and IL-6, and higher amount of MCP2/CCL8 than WT macrophages. MCP/CCL8 was induced via STAT3 and exhibited anti-tumor metastatic effect in WT mice. These data suggest that hyperactivation of STAT3 in myeloid cells simultaneously exerted an anti-inflammatory as well as anti-tumor effects. Thus, the targeted inhibition of SOCS3 activity in macrophages may be therapeutic for the suppression of tumor metastasis.

Original languageEnglish
Pages (from-to)172-180
Number of pages9
JournalCancer Letters
Volume308
Issue number2
DOIs
Publication statusPublished - 2011 Sep 28

Fingerprint

Macrophages
Cytokines
Neoplasm Metastasis
Neoplasms
Knockout Mice
Myeloid Cells
Melanoma
Interleukin-6
Cell Survival
Carcinogenesis
Anti-Inflammatory Agents
Transplantation
Phosphorylation
Inflammation
Lung
Liver
Growth

Keywords

  • Cytokine
  • MCP2/CCL8
  • SOCS3
  • STAT3
  • Tumor-associated macrophage

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction. / Hiwatashi, Kiyokazu; Tamiya, Taiga; Hasegawa, Eiichi; Fukaya, Tomohiro; Hashimoto, Masayuki; Kakoi, Kyosuke; Kashiwagi, Ikko; Kimura, Akihiro; Inoue, Naoko; Morita, Rimpei; Yasukawa, Hideo; Yoshimura, Akihiko.

In: Cancer Letters, Vol. 308, No. 2, 28.09.2011, p. 172-180.

Research output: Contribution to journalArticle

Hiwatashi, K, Tamiya, T, Hasegawa, E, Fukaya, T, Hashimoto, M, Kakoi, K, Kashiwagi, I, Kimura, A, Inoue, N, Morita, R, Yasukawa, H & Yoshimura, A 2011, 'Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction', Cancer Letters, vol. 308, no. 2, pp. 172-180. https://doi.org/10.1016/j.canlet.2011.04.024
Hiwatashi, Kiyokazu ; Tamiya, Taiga ; Hasegawa, Eiichi ; Fukaya, Tomohiro ; Hashimoto, Masayuki ; Kakoi, Kyosuke ; Kashiwagi, Ikko ; Kimura, Akihiro ; Inoue, Naoko ; Morita, Rimpei ; Yasukawa, Hideo ; Yoshimura, Akihiko. / Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction. In: Cancer Letters. 2011 ; Vol. 308, No. 2. pp. 172-180.
@article{7ef51dc610f54e299e39238e5cd16e7f,
title = "Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction",
abstract = "Inflammation has been demonstrated to play important roles in tumorigenesis, tumor progression, and metastasis. STAT3 has been shown to be frequently activated in a variety of human cancer cells and STAT3 signaling promotes the growth and survival of tumor cells. However, the role of STAT3 of myeloid cells associated with tumors is currently unknown. Suppressor of cytokine signaling-3 (SOCS3) has been shown to be a negative regulator of STAT3. In this study, we used macrophage specific SOCS3 conditional knockout (cKO) mice to investigate the effect of the hyperactivation of STAT3 in macrophages on tumor development and metastasis. In a subcutaneous transplantation model of B16F10 melanoma cells, although tumor sizes were not significantly different, SOCS3-cKO mice survived longer than wild-type (WT) mice did. SOCS3-cKO mice exhibited fewer lung and liver metastatic tumor nodules than WT mice when B16F10 was challenged intravenously. SOCS3-/- macrophages stimulated with tumor lysates in vitro exhibited prolonged STAT3 phosphorylation and produced less amount of TNFα and IL-6, and higher amount of MCP2/CCL8 than WT macrophages. MCP/CCL8 was induced via STAT3 and exhibited anti-tumor metastatic effect in WT mice. These data suggest that hyperactivation of STAT3 in myeloid cells simultaneously exerted an anti-inflammatory as well as anti-tumor effects. Thus, the targeted inhibition of SOCS3 activity in macrophages may be therapeutic for the suppression of tumor metastasis.",
keywords = "Cytokine, MCP2/CCL8, SOCS3, STAT3, Tumor-associated macrophage",
author = "Kiyokazu Hiwatashi and Taiga Tamiya and Eiichi Hasegawa and Tomohiro Fukaya and Masayuki Hashimoto and Kyosuke Kakoi and Ikko Kashiwagi and Akihiro Kimura and Naoko Inoue and Rimpei Morita and Hideo Yasukawa and Akihiko Yoshimura",
year = "2011",
month = "9",
day = "28",
doi = "10.1016/j.canlet.2011.04.024",
language = "English",
volume = "308",
pages = "172--180",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction

AU - Hiwatashi, Kiyokazu

AU - Tamiya, Taiga

AU - Hasegawa, Eiichi

AU - Fukaya, Tomohiro

AU - Hashimoto, Masayuki

AU - Kakoi, Kyosuke

AU - Kashiwagi, Ikko

AU - Kimura, Akihiro

AU - Inoue, Naoko

AU - Morita, Rimpei

AU - Yasukawa, Hideo

AU - Yoshimura, Akihiko

PY - 2011/9/28

Y1 - 2011/9/28

N2 - Inflammation has been demonstrated to play important roles in tumorigenesis, tumor progression, and metastasis. STAT3 has been shown to be frequently activated in a variety of human cancer cells and STAT3 signaling promotes the growth and survival of tumor cells. However, the role of STAT3 of myeloid cells associated with tumors is currently unknown. Suppressor of cytokine signaling-3 (SOCS3) has been shown to be a negative regulator of STAT3. In this study, we used macrophage specific SOCS3 conditional knockout (cKO) mice to investigate the effect of the hyperactivation of STAT3 in macrophages on tumor development and metastasis. In a subcutaneous transplantation model of B16F10 melanoma cells, although tumor sizes were not significantly different, SOCS3-cKO mice survived longer than wild-type (WT) mice did. SOCS3-cKO mice exhibited fewer lung and liver metastatic tumor nodules than WT mice when B16F10 was challenged intravenously. SOCS3-/- macrophages stimulated with tumor lysates in vitro exhibited prolonged STAT3 phosphorylation and produced less amount of TNFα and IL-6, and higher amount of MCP2/CCL8 than WT macrophages. MCP/CCL8 was induced via STAT3 and exhibited anti-tumor metastatic effect in WT mice. These data suggest that hyperactivation of STAT3 in myeloid cells simultaneously exerted an anti-inflammatory as well as anti-tumor effects. Thus, the targeted inhibition of SOCS3 activity in macrophages may be therapeutic for the suppression of tumor metastasis.

AB - Inflammation has been demonstrated to play important roles in tumorigenesis, tumor progression, and metastasis. STAT3 has been shown to be frequently activated in a variety of human cancer cells and STAT3 signaling promotes the growth and survival of tumor cells. However, the role of STAT3 of myeloid cells associated with tumors is currently unknown. Suppressor of cytokine signaling-3 (SOCS3) has been shown to be a negative regulator of STAT3. In this study, we used macrophage specific SOCS3 conditional knockout (cKO) mice to investigate the effect of the hyperactivation of STAT3 in macrophages on tumor development and metastasis. In a subcutaneous transplantation model of B16F10 melanoma cells, although tumor sizes were not significantly different, SOCS3-cKO mice survived longer than wild-type (WT) mice did. SOCS3-cKO mice exhibited fewer lung and liver metastatic tumor nodules than WT mice when B16F10 was challenged intravenously. SOCS3-/- macrophages stimulated with tumor lysates in vitro exhibited prolonged STAT3 phosphorylation and produced less amount of TNFα and IL-6, and higher amount of MCP2/CCL8 than WT macrophages. MCP/CCL8 was induced via STAT3 and exhibited anti-tumor metastatic effect in WT mice. These data suggest that hyperactivation of STAT3 in myeloid cells simultaneously exerted an anti-inflammatory as well as anti-tumor effects. Thus, the targeted inhibition of SOCS3 activity in macrophages may be therapeutic for the suppression of tumor metastasis.

KW - Cytokine

KW - MCP2/CCL8

KW - SOCS3

KW - STAT3

KW - Tumor-associated macrophage

UR - http://www.scopus.com/inward/record.url?scp=79959567446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959567446&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2011.04.024

DO - 10.1016/j.canlet.2011.04.024

M3 - Article

VL - 308

SP - 172

EP - 180

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -